Prof. Dr. med. Silke Gillessen Sommer
Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
Böhm S, Hess D, Gillessen Sommer S, Brändle M. Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib. Diabetes care 2010; 33:e82.
Jun 1, 2010Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib
Jun 1, 2010Diabetes care 2010; 33:e82
Böhm Steffen, Hess Dagmar, Gillessen Sommer Silke, Brändle Michael
Low-dose induction chemotherapy with Baby-BOP in patients with metastatic germ-cell tumours does not compromise outcome: a single-centre experience
Gillessen Sommer S, Powles T, Lim L, Wilson P, Shamash J. Low-dose induction chemotherapy with Baby-BOP in patients with metastatic germ-cell tumours does not compromise outcome: a single-centre experience. Ann Oncol 2010; 21:1589-93.
Feb 17, 2010Low-dose induction chemotherapy with Baby-BOP in patients with metastatic germ-cell tumours does not compromise outcome: a single-centre experience
Feb 17, 2010Ann Oncol 2010; 21:1589-93
Gillessen Sommer Silke, Powles T, Lim L, Wilson P, Shamash J
Primary manifestation of small lymphocytic lymphoma in the prostate
Fehr M, Templeton A, Cogliatti S, Aebersold F, Egli F, Gillessen Sommer S, Cathomas R. Primary manifestation of small lymphocytic lymphoma in the prostate. Onkologie 2009; 32:586-8.
Oct 1, 2009Primary manifestation of small lymphocytic lymphoma in the prostate
Oct 1, 2009Onkologie 2009; 32:586-8
Fehr Martin, Templeton Arnoud, Cogliatti Sergio B., Aebersold Franziska, Egli Fritz, Gillessen Sommer Silke, Cathomas Richard
Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07)
von Moos R, Goldinger S, Michielin O, Schuller J, Gillessen Sommer S, Schlaeppi M, Cathomas R, Ochsenbein A, Seifert B, Dummer R (2009). Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07). Presented at: ECCO / ESMO, Berlin
Sep 22, 2009Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07)
Sep 22, 2009ECCO / ESMO
von Moos Roger, Goldinger S., Michielin O., Schuller J.C., Gillessen Sommer Silke, Schlaeppi Marc, Cathomas R., Ochsenbein A., Seifert B., Dummer R.
Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma
Escudier B, Chen I, Maneval E, Flodgren P, Peschel C, Fountzilas G, Mulder S, Srinivas S, Harmenberg U, Gillessen Sommer S, Roigas J, Vogelzang N. Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:4068-75.
Sep 1, 2009Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma
Sep 1, 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:4068-75
Escudier Bernard, Chen Isan, Maneval Edna Chow, Flodgren Per, Peschel Christian, Fountzilas George, Mulder Sasja F, Srinivas Sandhya, Harmenberg Ulrika, Gillessen Sommer Silke, Roigas Jan, Vogelzang Nicholas J
Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung
Omlin A, D'Addario G, Gillessen Sommer S, Cerny T, Vonhessling A, Früh M. Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung. Lung cancer (Amsterdam, Netherlands) 2009; 65:383-4.
Sep 1, 2009Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung
Sep 1, 2009Lung cancer (Amsterdam, Netherlands) 2009; 65:383-4
Omlin Aurelius, D'Addario G, Gillessen Sommer Silke, Cerny Thomas, Vonhessling A, Früh Martin
Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib
Fokt R, Templeton A, Gillessen Sommer S, Öhlschlegel C, Schmid H. Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib. Urol Int 2009; 83:122-4.
Jul 27, 2009Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib
Jul 27, 2009Urol Int 2009; 83:122-4
Fokt Ralf-Michael, Templeton Arnoud, Gillessen Sommer Silke, Öhlschlegel Christian, Schmid Hans-Peter
'Sunitinib withdrawal phenomenon' or spontaneous regression in renal cell cancer
Rothermundt C, Omlin A, Gillessen Sommer S. 'Sunitinib withdrawal phenomenon' or spontaneous regression in renal cell cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009; 20:1144-6.
Jun 1, 2009'Sunitinib withdrawal phenomenon' or spontaneous regression in renal cell cancer
Jun 1, 2009Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009; 20:1144-6
Rothermundt Christian, Omlin Aurelius, Gillessen Sommer Silke
Concordant colon tumors in monozygotic twins previously treated for prostate cancer
Templeton A, Marra G, Valtorta E, Heinimann K, Müller H, Köberle D, Gillessen Sommer S. Concordant colon tumors in monozygotic twins previously treated for prostate cancer. Familial cancer 2009; 8:167-71.
Jan 1, 2009Concordant colon tumors in monozygotic twins previously treated for prostate cancer
Jan 1, 2009Familial cancer 2009; 8:167-71
Templeton Arnoud, Marra Giancarlo, Valtorta Emanuele, Heinimann Karl, Müller Hansjakob, Köberle Dieter, Gillessen Sommer Silke
Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer
Früh M, Gillessen Sommer S, Cerny T, Demmer-Steingruber R, D'Addario G. Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2008; 62:344-50.
Dec 1, 2008Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer
Dec 1, 2008Lung cancer (Amsterdam, Netherlands) 2008; 62:344-50
Früh Martin, Gillessen Sommer Silke, Cerny Thomas, Demmer-Steingruber Ruth, D'Addario G
CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study
Jörger M, Nuessli D, Henz S, Zaunbauer W, Cerny T, Cogliatti S, Gillessen Sommer S. CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study. Onkologie 2008; 31:514-9.
Oct 1, 2008CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study
Oct 1, 2008Onkologie 2008; 31:514-9
Jörger Markus, Nuessli Dominique, Henz Samuel, Zaunbauer Wolfgang, Cerny Thomas, Cogliatti Sergio B., Gillessen Sommer Silke
Metastatic bone pain: treatment options with an emphasis on bisphosphonates
von Moos R, Strasser F, Gillessen Sommer S, Zaugg K. Metastatic bone pain: treatment options with an emphasis on bisphosphonates. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008; 16:1105-15.
Oct 1, 2008Metastatic bone pain: treatment options with an emphasis on bisphosphonates
Oct 1, 2008Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008; 16:1105-15
von Moos Roger, Strasser Florian, Gillessen Sommer Silke, Zaugg Kathrin
Extraneural spread of glioblastoma--report of two cases
Templeton A, Hofer S, Toepfer M, Sommacal A, Fretz C, Cerny T, Gillessen Sommer S. Extraneural spread of glioblastoma--report of two cases. Onkologie 2008; 31:192-4.
Apr 1, 2008Extraneural spread of glioblastoma--report of two cases
Apr 1, 2008Onkologie 2008; 31:192-4
Templeton Arnoud, Hofer Silvia, Toepfer Michael, Sommacal Andreas, Fretz Christian, Cerny Thomas, Gillessen Sommer Silke
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
Templeton A, Brändle M, Cerny T, Gillessen Sommer S. Remission of diabetes while on sunitinib treatment for renal cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:824-5.
Apr 1, 2008Remission of diabetes while on sunitinib treatment for renal cell carcinoma
Apr 1, 2008Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:824-5
Templeton Arnoud, Brändle Michael, Cerny Thomas, Gillessen Sommer Silke
Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study
Strasser F, Demmer-Steingruber R, Böhme C, Schmitz S, Thürlimann B, Cerny T, Gillessen Sommer S. Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study. The Oncologist 2008; 13:337-46.
Mar 1, 2008Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study
Mar 1, 2008The Oncologist 2008; 13:337-46
Strasser Florian, Demmer-Steingruber Ruth, Böhme Christel, Schmitz Shu-Fang Hsu, Thürlimann Beat, Cerny Thomas, Gillessen Sommer Silke
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
Kisbenedek L, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof G, Ares L, Pizzocaro G, Mead G, Mason M, Klepp O, Kliesch S, Koehrmann K, Kollmannsberger C, Kuczyk M, Laguna P, Galvis O, Loy V, Pont J, Pottek T, Powles T, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, Skakkebaek N, Sedlmayer F, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz H, Schmidberger H, Schmoll H, Schrader M, von der Maase H, Jones W, Krege S, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder P, De Santis M, de Wit M, de Wit R, Classen J, Cavallin-Ståhl E, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Derigs H, Dieckmann K, Dieing A, Gillessen Sommer S, Hartmann J, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Germa-Lluch J, Gerl A, Droz J, Fenner M, Fizazi K, Flechon A, Fosså S, del Muro X, Gauler T, Geczi L, Joffe J. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. European urology 2008; 53:478-96.
Mar 1, 2008European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
Mar 1, 2008European urology 2008; 53:478-96
Kisbenedek László, Mueller Rolf, Nichols Craig, Nicolai Nicola, Oliver Tim, Ondrus Dalibor, Oosterhof Gosse O N, Ares Luis Paz, Pizzocaro Giorgio, Mead Graham M, Mason Malcolm D, Klepp Olbjørn, Kliesch Sabine, Koehrmann Kai Uwe, Kollmannsberger Christian, Kuczyk Markus, Laguna Pilar, Galvis Oscar Leiva, Loy Volker, Pont Jörg, Pottek Tobias, Powles Tom, Sohaib Aslam, Tjulandin Sergei, Warde Padraig, Weinknecht Stefan, Weissbach Lothar, Wittekind Christian, Winter Eva, Wood Lori, Skakkebaek Niels E, Sedlmayer Felix, Rick Oliver, Rosti Giovanni, Salvioni Roberto, Scheiderbauer Jutta, Schmelz Hans-Ulrich, Schmidberger Heinz, Schmoll Hans-Joachim, Schrader Mark, von der Maase Hans, Jones William G, Krege Susanne, Clemm Christoph, Cohn-Cedermark Gabriella, Culine Stéphane, Daugaard Gedske, De Mulder Pieter H M, De Santis Maria, de Wit Maike, de Wit Ronald, Classen Johannes, Cavallin-Ståhl Eva, Beyer Jörg, Souchon Rainer, Albers Peter, Albrecht Walter, Algaba Ferran, Bamberg Michael, Bodrogi István, Bokemeyer Carsten, Derigs Hans Günter, Dieckmann Klaus-Peter, Dieing Annette, Gillessen Sommer Silke, Hartmann Jörg T, Hartmann Michael, Heidenreich Axel, Hoeltl Wolfgang, Horwich Alan, Huddart Robert, Jewett Michael, Germa-Lluch Jose Ramon, Gerl Arthur, Droz Jean-Pierre, Fenner Martin, Fizazi Karim, Flechon Aude, Fosså Sophie D, del Muro Xavier Garcia, Gauler Thomas, Geczi Lajos, Joffe Johnathan
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
Kisbenedek L, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof G, Paz-Ares L, Pizzocaro G, Mead G, Mason M, Klepp O, Kliesch S, Koehrmann K, Kollmannsberger C, Kuczyk M, Laguna P, Galvis O, Loy V, Pont J, Pottek T, Powles T, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, Skakkebaek N, Sedlmayer F, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz H, Schmidberger H, Schmoll H, Schrader M, von der Maase H, Jones W, Krege S, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder P, De Santis M, de Wit M, de Wit R, Classen J, Cavallin-Ståhl E, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Derigs H, Dieckmann K, Dieing A, Gillessen Sommer S, Hartmann J, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Germa-Lluch J, Gerl A, Droz J, Fenner M, Fizazi K, Flechon A, Fosså S, del Muro X, Gauler T, Geczi L, Joffe J. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. European urology 2008; 53:497-513.
Mar 1, 2008European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
Mar 1, 2008European urology 2008; 53:497-513
Kisbenedek László, Mueller Rolf, Nichols Craig, Nicolai Nicola, Oliver Tim, Ondrus Dalibor, Oosterhof Gosse O N, Paz-Ares Luis, Pizzocaro Giorgio, Mead Graham M, Mason Malcolm D, Klepp Olbjørn, Kliesch Sabine, Koehrmann Kai Uwe, Kollmannsberger Christian, Kuczyk Markus, Laguna Pilar, Galvis Oscar Leiva, Loy Volker, Pont Jörg, Pottek Tobias, Powles Tom, Sohaib Aslam, Tjulandin Sergei, Warde Padraig, Weinknecht Stefan, Weissbach Lothar, Wittekind Christian, Winter Eva, Wood Lori, Skakkebaek Niels E, Sedlmayer Felix, Rick Oliver, Rosti Giovanni, Salvioni Roberto, Scheiderbauer Jutta, Schmelz Hans-Ulrich, Schmidberger Heinz, Schmoll Hans-Joachim, Schrader Mark, von der Maase Hans, Jones William G, Krege Susanne, Clemm Christoph, Cohn-Cedermark Gabriella, Culine Stéphane, Daugaard Gedske, De Mulder Pieter H M, De Santis Maria, de Wit Maike, de Wit Ronald, Classen Johannes, Cavallin-Ståhl Eva, Beyer Jörg, Souchon Rainer, Albers Peter, Albrecht Walter, Algaba Ferran, Bamberg Michael, Bodrogi István, Bokemeyer Carsten, Derigs Hans Günter, Dieckmann Klaus-Peter, Dieing Annette, Gillessen Sommer Silke, Hartmann Jörg T, Hartmann Michael, Heidenreich Axel, Hoeltl Wolfgang, Horwich Alan, Huddart Robert, Jewett Michael, Germa-Lluch Jose Ramon, Gerl Arthur, Droz Jean-Pierre, Fenner Martin, Fizazi Karim, Flechon Aude, Fosså Sophie D, del Muro Xavier Garcia, Gauler Thomas, Geczi Lajos, Joffe Johnathan
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
Steinbild S, Burkholder I, Edler L, Hanauske A, Hochhaus A, Strumberg D, Dittrich C, Gillessen Sommer S, Morant R, Frost A, Mross K, Scheulen M. A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. British journal of cancer 2007; 97:1480-5.
Dec 3, 2007A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
Dec 3, 2007British journal of cancer 2007; 97:1480-5
Steinbild S, Burkholder I, Edler L, Hanauske A-R, Hochhaus A, Strumberg D, Dittrich C, Gillessen Sommer Silke, Morant R, Frost A, Mross K, Scheulen M
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells
Enzler T, Gillessen Sommer S, Dougan M, Allison J, Neuberg D, Oble D, Mihm M, Dranoff G. Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells. Blood 2007; 110:954-61.
Aug 1, 2007Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells
Aug 1, 2007Blood 2007; 110:954-61
Enzler Thomas, Gillessen Sommer Silke, Dougan Michael, Allison James P, Neuberg Donna, Oble Darryl A, Mihm Martin, Dranoff Glenn
Increased pulmonary FDG uptake in bleomycin-associated pneumonitis
von Rohr L, Klaeser B, Jörger M, Kluckert T, Cerny T, Gillessen Sommer S. Increased pulmonary FDG uptake in bleomycin-associated pneumonitis. Onkologie 2007; 30:320-3.
Jun 1, 2007Increased pulmonary FDG uptake in bleomycin-associated pneumonitis
Jun 1, 2007Onkologie 2007; 30:320-3
von Rohr Lukas, Klaeser Bernd, Jörger Markus, Kluckert Thomas, Cerny Thomas, Gillessen Sommer Silke